Milrinone, >=97% (TLC), powder

Code: M4659-10MG D2-231

Biochem/physiol Actions

Phosphodiesterase type III inhibitor; cAMP-specific, cGMP-inhibitable; potent cardiotonic, positive inotropic vasodilator.

Features and ...


 Read more

Your Price
€315.73 10MG
€388.35 inc. VAT
REQUEST

Biochem/physiol Actions

Phosphodiesterase type III inhibitor; cAMP-specific, cGMP-inhibitable; potent cardiotonic, positive inotropic vasodilator.

Features and Benefits

This compound is featured on the Phosphodiesterases page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here.

This compound was developed by Sanofi Aventis. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.

This compound is a featured product for Cyclic Nucleotide research. Click here to discover more featured Cyclic Nucleotide products. Learn more about bioactive small molecules for other areas of research at sigma.com/discover-bsm.

Packaging

50 mg in glass bottle

10 mg in poly bottle

assay≥97% (TLC)
coloroff-white
formpowder
Gene Informationhuman ... PDE3A(5139), PDE3B(5140), PDE4B(5142), PDE5A(8654), PTPRA(5786)rat ... Pde3a(50678)
InChI keyPZRHRDRVRGEVNW-UHFFFAOYSA-N
InChI1S/C12H9N3O/c1-8-11(9-2-4-14-5-3-9)6-10(7-13)12(16)15-8/h2-6H,1H3,(H,15,16)
originatorSanofi Aventis
Quality Level200
SMILES stringCC1=C(C=C(C#N)C(=O)N1)c2ccncc2
solubilityDMSO: >10 mg/mL, H2O: insoluble
storage temp.2-8°C
Cas Number78415-72-2
Hazard Class6.1
Un Number2811
Pack GroupIII
This product has met the following criteria to qualify for the following awards:



PROCEED TO CHECKOUT

HAVE AN ACCOUNT? LOGIN
GUEST CHECKOUT

Proceed as a guest. You will have the option to register to access exclusive pricing and stock availability features after checkout.